卡托普利激发试验预测原发性醛固酮增多症患者的心脏结构与功能障碍
本研究回顾性分析540例原发性醛固酮增多症(PA)患者的卡托普利激发试验(CCT)及超声心动图数据。结果显示,CCT后血浆醛固酮浓度(PAC)与左心室质量指数(LVMI)、E/e'及左房容积指数(LAVI)呈线性关联,且CCT后PAC较高者经PA靶向治疗1年后心脏结构及舒张功能改善更显著。
要点
- CCT后PAC与基线LVMI、E/e'、LAVI独立相关,呈连续风险关系。
- CCT后PAC较高者经PA靶向治疗1年后LVMI、E/e'、LAVI改善更明显。
- 基线醛固酮仅与基线LVMI及其改善相关,与E/e'、LAVI无关。
核心结论
- 较高的CCT后PAC与更差的左心室重构和舒张功能障碍显著相关,但也与靶向治疗后心脏结构及功能更大改善相关。
- CCT后PAC可预测PA患者心脏疾病严重程度及治疗获益潜力。
研究设计与样本
- 回顾性分析540例具有完整CCT和超声心动图数据的PA患者,评估基线及PA靶向治疗1年后的临床和超声心动图参数。
主要发现
- 限制性立方样条分析显示CCT后PAC与LVMI和E/e'均呈显著线性关联。
- 线性回归分析中,CCT后PAC与基线LVMI、E/e'、LAVI显著相关,且不受多模型调整影响。
- PA靶向治疗1年后,CCT后PAC较高的患者LVMI、E/e'、LAVI改善最大。
- 基线醛固酮仅与基线LVMI及其治疗后改善相关,与E/e'或LAVI的基线值或改善无关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The captopril challenge test (CCT) is a commonly used confirmation test that identifies the magnitude of renin- and angiotensin II-independent aldosterone production and thus the presence and severity of primary aldosteronism (PA). OBJECTIVE: This study investigated the association between the post-CCT plasma aldosterone concentration (PAC) and cardiovascular remodeling and diastolic dysfunction. METHODS: A total of 540 PA patients with complete CCT and echocardiographic data were retrospectively analyzed. Clinical and echocardiographic parameters were assessed at baseline and 1 year after PA-targeted treatment. RESULTS: The post-CCT PAC showed a significant linear association with both left ventricular mass index (LVMI) and the ratio of early diastolic transmitral and myocardial velocity on tissue Doppler imaging (E/e') in restricted cubic spline analyses, indicating a continuum of risk linked to postcaptopril aldosterone levels. In linear regression analyses, post-CCT PAC was significantly associated with baseline LVMI, E/e', and left atrial volume index (LAVI), regardless of multiple model adjustments. One year after PA-targeted treatment, patients with higher post-CCT PAC experienced the greatest improvements in LVMI, E/e', and LAVI. In contrast, baseline aldosterone levels were associated only with baseline LVMI and its improvement after treatment but not with the baseline or improvement of E/e' or LAVI. CONCLUSION: Higher post-CCT PAC was significantly associated with worse left ventricular remodeling and diastolic dysfunction but also greater improvements in cardiac structure and dysfunction following targeted treatment. These findings highlight the prognostic and therapeutic values of the CCT that the post-CCT PAC predicts the severity of cardiac disease and also the potential for therapeutic benefits in PA.
引用
- Chen UL, Liao CW, Wang SM, et al. The Captopril Challenge Test Predicts Cardiac Structure and Dysfunction in Primary Aldosteronism. J Clin Endocrinol Metab. 2025. PMID: 39745835. doi:10.1210/clinem/dgae907
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。